Large Decrease Seen in Melanoma Mortality From 2013 to 2016
From 2013 to 2016, there was a large decrease of 17.9 percent in melanoma mortality.
Melanoma
BRAF V600E Mutation is Prognostic Indicator for Cutaneous Melanoma
BRAF V600E mutation may indicate a reduced risk for relapse and/or metastasis in patients with melanoma.
Bereavement Tied to Higher Melanoma-Related Mortality
There is a decreased risk for melanoma diagnosis among bereaved individuals but increased mortality associated with melanoma compared with nonbereaved individuals.
Does Methotrexate Increase Risk for Cutaneous Malignant Melanoma in Patients With Psoriasis?
Physicians may be reassured, when prescribing methotrexate to their patients with psoriasis, as no association between methotrexate exposure and risk for cutaneous malignant melanoma was noted in a sizeable study.
High Cutaneous Melanoma Burden Found Due to UV Radiation
The percentage of cases of cutaneous melanoma and age-standardized incidence rates attributable to ultraviolet radiation vary across states.
Studies Explore Prevalence of Skin Cancer Among Sexual Minorities
The researchers found that compared with heterosexual men, gay and bisexual men had significantly higher adjusted odds ratios of skin cancer prevalence.
Blood Mercury Levels Linked to Nonmelanoma Skin Cancer
Blood mercury levels are associated with nonmelanoma skin cancer.
Circulating Tumor Cells Predict Relapse in Stage III Melanoma
For stage III melanoma patients, circulating tumor cells predict relapse.
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Risk Factors Associated With Central Nervous System Metastasis in Stage III Melanoma
Researchers aimed to identify clinicopathologic characteristics of patients with stage III melanoma who would benefit from regular CNS imaging.
Next post in Skin Cancer
